CClinicalTrials.gg
Status unknownNCT02077205Updated Mar 4, 2014

Manualised Cognitive Behavioral Therapy of Anxiety Disorders in Children and Adolescents in Routine Care Setting

An interventional study of Manualised Cognitive Behavioral Therapy in Anxiety Disorders, sponsored by Ruhr University of Bochum. Status unknown at 1 site in Germany. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2014-03-04.

Sponsored by Ruhr University of Bochum · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
4 Years to 18 Years
Sex
All
01

Study summary

Manualised Cognitive Behavioral Therapy for children and adolescents with anxiety disorders is evaluated in a routine care setting to evaluate the efficacy of the intervention. Children and adolescents receive manualized Cognitive Behavioral Therapy for anxiety disorder.

It is expected, that the intervention will result in less anxiety / lower scores on the primary and secondary outcome measures.

02

Conditions studied

  • Anxiety Disorders

Browse trials for

Keywords

  • Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's planned enrollment of 200 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Ruhr University of Bochum is the lead sponsor of 124 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children and adolescents aged 4-18 years
  • Primary diagnosis of an anxiety disorder:

    1. Generalized Anxiety Disorder
    2. Social Phobia
    3. Separation Anxiety Disorder
    4. Panic Disorder +/- Agoraphobia
    5. Specific Phobia

Exclusion criteria

Exclusion Criteria:

  • Other primary diagnoses
  • Significant intellectual impairment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Manualised Cognitive Behavioral Therapy

    Manualised Cognitive Behavioral Therapy in a Routine Care Setting

    Behavioral: Manualised Cognitive Behavioral Therapy

Interventions

  • BehavioralManualised Cognitive Behavioral Therapy

    16 Sessions of Manualised Cognitive Behavioral Therapy in a Routine Care Setting

06

What researchers measure

Primary outcomes

  1. Severity rating of diagnosis (according to the Kinder-DIPS)

    Time frame: Changes in severity rating from pre- to post-assessment (post-assessment takes place 30 weeks after the pre-assessment on average) and to 6-month-follow-up (which takes place about 6 months after the post-assessment)

  2. Spence Children's Anxiety Scale (SCAS)

    Time frame: Changes on the SCAS from pre- to post-assessment (post-assessment takes place 30 weeks after the pre-assessment on average) and to 6-month-follow-up (which takes place about 6 months after the post-assessment)

  3. Clinical Global Improvement Impression (CGI-I)

    Time frame: Changes on the CGI-I from post-assessment (post-assessment takes place 30 weeks after the pre-assessment on average) to 6-month-follow-up (which takes place about 6 months after the post-assessment)

  4. Interference rating as assessed by the "Beurteilung der Beeinträchtigung/ Einschränkung des Patienten" (BEE)

    The German questionnaire "Beurteilung der Beeinträchtigung/ Einschränkung des Patienten" (BEE) assesses the degree of interference.

    Time frame: Changes in interference rating from pre- to post-assessment (post-assessment takes place 30 weeks after the pre-assessment on average) and to 6-month-follow-up (which takes place about 6 months after the post-assessment)

Secondary outcomes

  1. Depression as measured by the Short Moods and Feelings Questionnaire (SMFQ)

    Time frame: Changes in the SMFQ from pre- to post-assessment (post-assessment takes place 30 weeks after the pre-assessment on average) and to 6-month-follow-up (which takes place about 6 months after the post-assessment)

  2. Strengths and Difficulties Questionnaire (SDQ)

    Time frame: Changes on the SDQ from pre- to post-assessment (post-assessment takes place 30 weeks after the pre-assessment on average) and to 6-month-follow-up (which takes place about 6 months after the post-assessment)

07

Study locations

1 of 1 sites recruiting
  • Ruhr-University of Bochum, Department of Psychology, AE Klinische Kinder- und Jugendpsychologie
    Bochum, Nordrhein-Westfalen 44787, Germany
    • Britta Bredenbröcker · Contact · britta.bredenbroecker@rub.de · +49 (0)234 32 - 23168
    • Silvia Schneider, Prof. Dr. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02077205
Lead sponsor
Ruhr University of Bochum
Responsible party
Prof. Dr. Silvia Schneider (Prof. Dr., Ruhr University of Bochum) — Principal investigator
First posted
Mar 4, 2014
Start date
Jan 2012
Primary completion
Jun 2014 (estimated)
Completion
Dec 2015 (estimated)
Last update
Mar 4, 2014

Study contacts

Silvia Schneider, Prof. Dr.
Contact
silvia.schneider@rub.de
+49 (0)234 32 - 23168

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion